Zhilina Zhanna V, Ziemba Amy J, Ebbinghaus Scot W
Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.
Curr Top Med Chem. 2005;5(12):1119-31. doi: 10.2174/156802605774370892.
Artificial control of gene expression has great potential in the treatment of many human diseases, and peptide nucleic acids (PNAs) offer several potential advantages for silencing gene expression in mammalian cells. The pseudopeptide backbone of the PNA makes it resistant to enzymatic degradation, and PNAs bind complementary DNA and RNA with high affinity and specificity. PNAs are potentially leading agents for antigene and antisense therapeutics, but the application of PNAs in the in vivo setting is hampered by their poor intracellular delivery. This problem has been addressed by PNA conjugation to lipophilic moieties, peptides, and cell-specific receptor ligands. The biological activity of PNAs can also benefit from conjugation to DNA interactive compounds like intercalators and alkylators. Here we review the most interesting literature concerning PNA conjugation with small molecules, emphasizing synthetic approaches, properties and applications of the PNA conjugates.
基因表达的人工控制在许多人类疾病的治疗中具有巨大潜力,而肽核酸(PNA)在沉默哺乳动物细胞中的基因表达方面具有若干潜在优势。PNA的假肽骨架使其具有抗酶降解能力,并且PNA能以高亲和力和特异性结合互补DNA和RNA。PNA有可能成为反基因和反义治疗的先导药物,但其在体内应用时因细胞内递送不佳而受到阻碍。通过将PNA与亲脂性基团、肽和细胞特异性受体配体偶联,这一问题已得到解决。PNA与嵌入剂和烷化剂等DNA相互作用化合物偶联后,其生物活性也会得到提升。在此,我们综述了关于PNA与小分子偶联的最有趣的文献,重点介绍了PNA偶联物的合成方法、性质及应用。